Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy

Results

Title:	Genomic variation in the MAP3K5 gene is associated with beta-thalassemia disease severity and hydroxyurea treatment efficacy
Authors:	Tafrali, Christina; Paizi, Arsinoi; Borg, Joseph; Radmilović Milena ; Bartsakoulia, Marina; Giannopoulou, Emily; Giannakopoulou, Olga; Stojiljković, Maja ; Zukić, Branka ; Poulas, Konstantinos; Stavrou, Eleana F; Lambropoulou, Polyxeni; Kourakli, Alexandra; Felice, Alexander E; Papachatzopoulou, Adamantia; Philipsen, Sjaak; Pavlović, Sonja ; Georgitsi, Marianthi; Patrinos, George P;
Issue Date:	2013
Publication:	Pharmacogenomics
ISSN:	1462-2416 Pharmacogenomics Search Idenfier
Publisher:	Future Medicine Ltd, London
Type:	Article
Collation:	vol. 14 br. 5 str. 469-483
DOI:	10.2217/pgs.13.31
WoS-ID:	000317177700012
Scopus-ID:	2-s2.0-84875936756
PMID:	23556445
URI:	https://imagine.imgge.bg.ac.rs/handle/123456789/640 https://enauka.gov.rs/handle/123456789/284966
Project:	long-term EMBO fellowship [ALTF 71-2011] Research Promotion Foundation of Cyprus grant [RPFPiLambdaE046_02] European Commission grant [FP7-200754] 'SEE-DRUG' project [FP7-REGPOT-2011-1]
Metadata source:	Migracija
M-category:	21M21

27
SCOPUS^TM

9
PubMed Central^TM

21
OpenCitations

26
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall